| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 01/12/2006 | US20060009462 Prodrugs of CC-1065 analogs |
| 01/12/2006 | US20060009446 New compounds |
| 01/12/2006 | CA2572874A1 Urea derivative |
| 01/12/2006 | CA2570169A1 Azine-carboxamides as anti-cancer agent |
| 01/12/2006 | CA2569545A1 Collection of traceable compounds and uses thereof |
| 01/11/2006 | CN1720238A Neurologically-active compounds |
| 01/11/2006 | CN1720224A Vasculostatic agents and methods of use thereof |
| 01/11/2006 | CN1235870C Novel use of phenyl hetero alkylamine derivatives |
| 01/10/2006 | US6984637 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 01/10/2006 | US6984462 Organic electroluminescent devices using double-spiro organic compounds |
| 01/05/2006 | WO2006000288A1 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes |
| 01/05/2006 | WO2003031406A3 Kinase inhibitor scaffolds and methods for their preparation |
| 01/05/2006 | US20060004197 Sulfonamide-based compounds as protein tyrosine kinase inhibitors |
| 01/05/2006 | US20060004048 Novel biaromatic compounds which activate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 01/05/2006 | US20060004010 Ccr4 antagonist and medical use thereof |
| 01/05/2006 | DE69828607T2 CHINOLIN- UND CHINOXALIN-VERBINDUNGEN DIE DEN VON BLUTPLÄTTCHEN ABSTAMMMENDEN WACHSTUMSFAKTOR UND/ODER PDGF- UND P56lck-TYROSIN-KINASE HEMMEN Quinoline and quinoxaline THE COMPOUNDS OF THE PLATELET FACTOR ABSTAMMMENDEN GROWTH AND / OR PDGF-TYROSINE KINASE AND p56 HEMMEN |
| 01/05/2006 | CA2572153A1 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes |
| 01/04/2006 | EP1611088A2 Hydroxamates as therapeutic agents |
| 01/04/2006 | EP1610753A2 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
| 01/04/2006 | EP1363873A4 Peptide deformylase inhibitors |
| 01/04/2006 | CN1715280A Aryl fused azapolycyclic compounds |
| 01/03/2006 | US6982267 For therapy of metabolic and eating disorders such as obesity and hyperphagia, and therapy of diabetes |
| 01/03/2006 | CA2156289C Drug composition containing nucleic acid copolymer |
| 12/29/2005 | WO2005123746A1 Methods for preparation of levofloxacin and ofloxacin |
| 12/29/2005 | WO2005123698A1 Fungicides based on nitrogen-containing heterocycles |
| 12/29/2005 | WO2005123089A2 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 12/29/2005 | US20050288304 Tetrahydronaphthylpiperazines as 5HT1B antagonists, inverse agonists and partial agonists |
| 12/29/2005 | US20050288294 N-ethyl-N'-{(3R)-1-[4-(3-phenylthieno[3,4-b]pyrazin-2-yl)benzyl]pyrrolidin-3-yl}urea; inhibit activity of a serine, threonine protein kinase; cancer |
| 12/29/2005 | US20050288293 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors |
| 12/28/2005 | EP1608374A1 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders |
| 12/28/2005 | EP1332138B1 Radiopharmaceuticals for diagnosing alzheimer's disease |
| 12/28/2005 | CN1233632C Process for enhancement of cycle life of zinc chromium based catalyst used in synthesis of 2-methyl pyrazine |
| 12/28/2005 | CN1233618C Benzoylcyclohexanone amine compounds with herbicidal activity |
| 12/27/2005 | US6979737 Quinoxaline-containing AB2 monomer for hyperbranched aromatic poly(ether-ketones) |
| 12/22/2005 | WO2005121095A1 Pyridine analogs as c5a antagonists |
| 12/22/2005 | WO2005120494A1 1-`(3r)-amino-4-(2-fluoro-phenyl)-butyl !-pyrrolidine-(2r)-carboxilic acid-benzyl amine derivatives and related compounds as dipeptidyl-peptidase iv (dpp-iv) inhibitors for the treatment of type 2 diabetes mellitus |
| 12/22/2005 | WO2005113537A3 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 12/22/2005 | US20050282905 Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient |
| 12/22/2005 | US20050282881 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/22/2005 | US20050282872 Novel thyroid receptor ligands and method II |
| 12/22/2005 | US20050282814 Vasculostatic agents and methods of use thereof |
| 12/22/2005 | US20050282812 Inhibitors of cholesteryl ester transfer protein |
| 12/22/2005 | US20050282787 Synthesis of tetracyclines and analogues thereof |
| 12/22/2005 | CA2576236A1 1-`(3r)-amino-4-(2-fluoro-phenyl)-butyl !-pyrrolidine-(2r)-carboxilic acid-benzyl amine derivatives and related compounds as dipeptidyl-peptidase iv (dpp-iv) inhibitors for the treatment of type 2 diabetes mellitus |
| 12/22/2005 | CA2568673A1 Pyridine analogs as c5a antagonists |
| 12/21/2005 | EP1607393A1 Compositions comprising hydroalkylated direct dyestuffs, process for implementing and use |
| 12/21/2005 | EP1606267A1 Pyrazine compounds as transforming growth factor (tgf) inhibitors |
| 12/21/2005 | EP1606266A2 Chemical compounds |
| 12/21/2005 | EP1606251A2 Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor |
| 12/21/2005 | EP1363897B1 Antagonists of mcp-1 function and methods of use thereof |
| 12/21/2005 | EP1362039B1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 12/21/2005 | EP1178973B1 Pyrazinyl-piperazine- compounds, their use and preparation |
| 12/21/2005 | CN1711257A Aryl sulfonamides |
| 12/20/2005 | US6977258 Antiinflammatory agents; cardiotonic agents; rheumatic diseases |
| 12/15/2005 | WO2005118651A1 Alkoxyamines containing a radically polymerizable group |
| 12/15/2005 | WO2005117883A1 Modulators of muscarinic receptors |
| 12/15/2005 | WO2005117543A2 N-sulfonylcarboximidamide apoptosis promoters |
| 12/15/2005 | US20050277649 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors; potentiation; diabetes and obesity; 2-(4-{4-[1-(6-chloro-pyridin-3-yl)cyclopropylmethyl]-2-(R)-methyl-piperazine-1-sulfonyl}phenyl)-1,1,1-trifluoro-propan-2-ol |
| 12/15/2005 | US20050277647 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme |
| 12/15/2005 | US20050277646 N-[4-({5-(4-fluorophenyl)-4-[4-(trifluoromethyl)phenyl]pyridin-2-yl}oxy)-1,3-benzothiazol-2-yl]acetamide; vanilloid (capsaicin) receptor antagonist/agonist; antiinflammatory, analgesic, antiarthritis, antirheumatic; diseases involving sensory nerve function |
| 12/15/2005 | US20050277644 Pyridine analogs as C5a antagonists |
| 12/15/2005 | US20050277631 Vanilloid receptor ligands and their use in treatments |
| 12/15/2005 | DE102004022765A1 Verfahren zur Herstellung von Monoarylpiperazinen A process for preparing Monoarylpiperazinen |
| 12/15/2005 | CA2568524A1 Modulators of muscarinic receptors |
| 12/15/2005 | CA2567831A1 N-sulfonylcarboximidamide apoptosis promoters |
| 12/14/2005 | EP1604662A1 1-[(3R)-Amino-4-(2-fluoro-phenyl)-butyl]-pyrrolidine-(2R)-carboxylic acid benzyl amine derivatives and related compounds as dipeptidyl peptidase IV (DPP-IV) inhibitors for the treatment of type 2 diabetes mellitus |
| 12/14/2005 | EP1224165B1 Novel compounds |
| 12/14/2005 | CN1231473C Substituted arylpyrazines |
| 12/14/2005 | CN1231440C Novel tricyclic compound |
| 12/13/2005 | US6974876 Method for preparing intermediates useful in synthesis of retroviral protease inhibitors |
| 12/13/2005 | US6974869 Piperizinones as modulators of chemokine receptor activity |
| 12/13/2005 | US6974817 CCR1 receptor antagonists; inhibitors of MIP-1 alpha (CCL3) binding to its receptor CCR1 found on inflammatory and immunomodulatory cells; macrophage inflammatory protein (MIP) |
| 12/08/2005 | WO2005115995A1 Amine compound and organic electroluminescent element employing the same |
| 12/08/2005 | WO2005115994A1 Substituted pyrazinecarboxylic acid anilide derivatives or salts thereof, intermediates of the same, pesticides for agricultural and horticultural use, and usage thereof |
| 12/08/2005 | WO2005115986A1 Therapeutic compounds: pyridine as scaffold |
| 12/08/2005 | WO2005115983A1 Aryl sulfonamide and sulfonyl compounds as modulators of ppar and methods of treating metabolic disorders |
| 12/08/2005 | US20050272931 Vanilloid receptor ligands and their use in treatments |
| 12/08/2005 | US20050272777 Vanilloid receptor ligands and their use in treatments |
| 12/08/2005 | US20050272745 Novel piperidine and piperazine derivatives |
| 12/08/2005 | US20050272744 N-((4-((( 1R)-3 -(dimethylamino)-1-((phenylsulfanyl)methyl)propyl)amino)-3-nitrophenyl)sulfonyl)-4-(4-(2-fluorobenzyl)-4-methoxy-1-piperidinyl)benzenecarboximidamide; trigger apoptosis through the inhibition of the Bcl family of proteins |
| 12/08/2005 | US20050272088 Dark quenchers for donor-acceptor energy transfer |
| 12/08/2005 | CA2565065A1 Therapeutic compounds: pyridine as scaffold |
| 12/08/2005 | CA2564638A1 Aryl sulfonamide and sulfonyl compounds as modulators of ppar and methods of treating metabolic disorders |
| 12/07/2005 | EP1602368A2 Cdc25 phosphatase inhibitors |
| 12/07/2005 | EP1199306B1 Biarylurea derivatives |
| 12/06/2005 | US6972340 For therapy of diabetes, obesity, autoimmune disorders, acute and chronic inflammatory disorders, osteoporosis, cancer, malignant disorders |
| 12/06/2005 | US6972297 2-Hydroxy-mutilin carbamate derivatives for antibacterial use |
| 12/06/2005 | US6972290 Piperazine derivatives and their use as anti-inflammatory agents |
| 12/06/2005 | CA2148593C Use of piperazine derivatives for the treatment of cognitive disorders |
| 12/06/2005 | CA2096528C Retroviral protease inhibitors |
| 12/01/2005 | WO2005113542A2 N-cyclic sulfonamido inhibitors of gamma secretase |
| 12/01/2005 | WO2005113537A2 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 12/01/2005 | WO2005113527A1 Tetrahydronaphthyl- piperazines as 5-ht1b antagonists, inverse agonists and partial agonists |
| 12/01/2005 | WO2005112945A2 Synthesis of tetracyclines and analogues thereof |
| 12/01/2005 | WO2005112925A1 Aryl sulfonamides |
| 12/01/2005 | WO2005112916A2 Bis-aryl sulfonamides |
| 12/01/2005 | WO2005112630A1 Quinoxalin-2-one derivatives crop protection agents comprising the same and method for production and use therof |
| 12/01/2005 | WO2005042516A3 Ligands of melanocortin receptors and compositions and methods related thereto |
| 12/01/2005 | WO2004085401A8 1,2,4-substituted 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity |
| 12/01/2005 | US20050267304 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders |